Pre-Market Engagement - Mandibular Advancement Device Provision

PRE-MARKET ENGAGEMENT The University Hospitals of North Midlands wishes to hear from organisations willing to share information about the provision of who can deliver a full Mandibular Advancement Device (MAD) Therapy Pathway to patients referred by the healthcare professionals, to gauge the likely level of interest in this provision from the market. For the avoidance of doubt, this soft market testing exercise is an exploratory exercise to determine feasibility and not a call for competition. It does not constitute any commitment by the Trust to undertake a procurement exercise.